Cargando…

A Nomogram Predicts Individual Prognosis in Patients With Newly Diagnosed Glioblastoma by Integrating the Extent of Resection of Non-Enhancing Tumors

BACKGROUND: The extent of resection of non-contrast enhancing tumors (EOR-NCEs) has been shown to be associated with prognosis in patients with newly diagnosed glioblastoma (nGBM). This study aimed to develop and independently validate a nomogram integrated with EOR-NCE to assess individual prognosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhe, Jin, Zeping, Liu, Dayuan, Zhang, Yang, Li, Chunzhao, Miao, Yazhou, Chi, Xiaohan, Feng, Jie, Wang, Yaming, Hao, Shuyu, Ji, Nan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739947/ https://www.ncbi.nlm.nih.gov/pubmed/33344248 http://dx.doi.org/10.3389/fonc.2020.598965

Ejemplares similares

Extent of Resection in Newly Diagnosed Glioblastoma: Impact of a Specialized Neuro-Oncology Care Center
por: Haj, Amer, et al.
Publicado: (2017)

Anti‐cancer effect of targeting fibroblast activation protein alpha in glioblastoma through remodeling macrophage phenotype and suppressing tumor progression
por: Miao, Yazhou, et al.
Publicado: (2022)

The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype Glioblastoma
por: Incekara, Fatih, et al.
Publicado: (2020)

Fluorescein-guided resection of newly diagnosed high-grade glioma: Impact on extent of resection and outcome
por: Schebesch, Karl-Michael, et al.
Publicado: (2022)

Resection of Noncontrast-Enhancing Regions Deteriorated the Immunotherapeutic Efficacy of HSPPC-96 Vaccination in Treating Glioblastoma
por: Chi, Xiaohan, et al.
Publicado: (2022)

Pre-operative Neurocognitive Function Was More Susceptible to Decline in Isocitrate Dehydrogenase Wild-Type Subgroups of Lower-Grade Glioma Patients
por: Zhang, Zhe, et al.
Publicado: (2020)

Accuracy of the neurosurgeons estimation of extent of resection in glioblastoma
por: Sezer, Sümeyye, et al.
Publicado: (2019)

Avelumab in newly diagnosed glioblastoma
por: Jacques, Francois H, et al.
Publicado: (2021)

Impact of time to initiation of radiotherapy on survival after resection of newly diagnosed glioblastoma
por: Katsigiannis, Sotirios, et al.
Publicado: (2019)

Effect of Cadherin-11 Expression on the Prognosis of a Newly Diagnosed Primary Glioblastoma
por: Seo, Hyunwoo, et al.
Publicado: (2021)

Supramaximal Resection for Glioblastoma: Redefining the Extent of Resection Criteria and Its Impact on Survival
por: Roh, Tae Hoon, et al.
Publicado: (2023)

Advances in the treatment of newly diagnosed glioblastoma
por: Theeler, Brett J., et al.
Publicado: (2015)

A Review of Newly Diagnosed Glioblastoma
por: Oronsky, Bryan, et al.
Publicado: (2021)

Newly Diagnosed Glioblastoma in Elderly Patients
por: Yuen, Carlen A., et al.
Publicado: (2022)

A nomogram for individualized prediction of overall survival in patients with newly diagnosed glioblastoma: a real-world retrospective cohort study
por: Kudulaiti, Nijiati, et al.
Publicado: (2021)

Prognostic Nomogram for the Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
por: Zhang, Yue, et al.
Publicado: (2019)

Circulating Plasma Cells as a Biomarker to Predict Newly Diagnosed Multiple Myeloma Prognosis: Developing Nomogram Prognostic Models
por: Cheng, Qianwen, et al.
Publicado: (2021)

Correction: Newly Diagnosed Glioblastoma in Elderly Patients
por: Yuen, Carlen A., et al.
Publicado: (2022)

Interstitial photodynamic therapy for newly diagnosed glioblastoma
por: Quach, Stefanie, et al.
Publicado: (2023)

Modeling the efficacy of the extent of surgical resection in the setting of radiation therapy for glioblastoma
por: Hathout, Leith, et al.
Publicado: (2016)

The prognosis for patients with newly diagnosed glioblastoma receiving bevacizumab combination therapy: a meta-analysis
por: Liao, Ke-Li, et al.
Publicado: (2018)

Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825
por: Patil, Nirav, et al.
Publicado: (2021)

What is the advance of extent of resection in glioblastoma surgical treatment—a systematic review
por: Wang, Lei, et al.
Publicado: (2019)

The influence of subventricular zone involvement in extent of resection and tumor growth pattern of glioblastoma
por: Ahmadipour, Yahya, et al.
Publicado: (2020)

Extent of resection and survival in patients with glioblastoma multiforme: Systematic review and meta-analysis
por: Revilla-Pacheco, Francisco, et al.
Publicado: (2021)

Low MxA Expression Predicts Better Immunotherapeutic Outcomes in Glioblastoma Patients Receiving Heat Shock Protein Peptide Complex 96 Vaccination
por: Wang, Yi, et al.
Publicado: (2022)

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme
por: Fazeny-Dörner, B, et al.
Publicado: (2003)

Subclassification of Newly Diagnosed Glioblastomas through an Immunohistochemical Approach
por: Conroy, Siobhan, et al.
Publicado: (2014)

Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome
por: Weller, Michael, et al.
Publicado: (2016)

Radiotherapy for Newly Diagnosed Glioblastoma in the Elderly: What Is the Standard?
por: Wee, Chan Woo
Publicado: (2022)

Feasibility, Safety and Impact on Overall Survival of Awake Resection for Newly Diagnosed Supratentorial IDH-Wildtype Glioblastomas in Adults
por: Moiraghi, Alessandro, et al.
Publicado: (2021)

T cell receptor repertoire as a prognosis marker for heat shock protein peptide complex-96 vaccine trial against newly diagnosed glioblastoma
por: Zhang, Yang, et al.
Publicado: (2020)

Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group
por: Karschnia, Philipp, et al.
Publicado: (2022)

Survival impact of delaying postoperative chemoradiotherapy in newly-diagnosed glioblastoma patients
por: Zhang, Maochen, et al.
Publicado: (2020)

Are we providing best-available care to newly diagnosed glioblastoma patients? Systematic review of phase III trials in newly diagnosed glioblastoma 2005–2022
por: Oster, Christoph, et al.
Publicado: (2023)

Unplanned 30-Day Readmission in Glioblastoma Patients: Implications for the Extent of Resection and Adjuvant Therapy
por: Kasper, Johannes, et al.
Publicado: (2023)

Magnetic Resonance Imaging-Based Radiomic Profiles Predict Patient Prognosis in Newly Diagnosed Glioblastoma Before Therapy
por: McGarry, Sean D., et al.
Publicado: (2016)

The Prognosis of Anti-Angiogenesis Treatments Combined with Standard Therapy for Newly Diagnosed Glioblastoma: A Meta-Analysis of Randomized Controlled Trials
por: Li, Yuping, et al.
Publicado: (2016)

Radiomics and MGMT promoter methylation for prognostication of newly diagnosed glioblastoma
por: Sasaki, Takahiro, et al.
Publicado: (2019)

Bench to bedside radiosensitizer development strategy for newly diagnosed glioblastoma
por: Degorre, Charlotte, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9h4q0me3okicai9g181gck7ot9